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Introduction: There is limited literature regarding the peri-operative and surgical management of patients with
rheumatoid disease undergoing lower limb arthroplasty. This review article summarises factors involved in the
peri-operative management of major lower limb arthroplasty surgery for patients with rheumatoid arthritis.
Methods: We performed a search of the medical literature, using the PubMed search engine (www.pubmed.
gov). We used the following terms: ‘rheumatoid’ ‘replacement’ ‘arthroplasty’ and ‘outcome’.
Findings: The patient should be optimised pre-operatively using a multidisciplinary approach. The continued use
of methotrexate does not increase infection risk, and aids recovery. Biologic agents should be stopped
pre-operatively due the increased infection rate. Patients should be made aware of the increased risk of infection
and periprosthetic fracture rates associated with their disease. The surgical sequence is commonly hip, knee and
then ankle. Cemented total hip replacement (THR) and total knee replacement (TKR) have superior survival rates
over uncemented components. The evidence is not clear regarding a cruciate sacrificing versus retaining in TKR,
but a cruciate sacrificing component limits the risk early instability and potential revision. Patella resurfacing as
part of a TKR is associated with improved outcomes. The results of total ankle replacement remain inferior to
THR and TKR. RA patients achieve equivalent pain relief, but their rehabilitation is slower and their functional
outcome is not as good. However, the key to managing these complicated patients is to work as part of a
multidisciplinary team to optimise their outcome.Introduction
Rheumatoid arthritis (RA) is a chronic systemic connect-
ive tissue disease and is the third most common indica-
tion for lower limb joint replacement in Northern
Europe and North America [1]. The aetiology of the dis-
ease remains unclear but there are strong associations
with Human Leukocyte Antigens (DRB1) [2]. The prog-
nosis is poor with 80% of patients being disabled 20 years
from primary diagnosis [3]. The medical treatment of
RA has improved during the last 25 years, which is
reflected by a 40% decrease in the rate of hip and knee
surgery since a peak that was observed in the mid 1990s
[4]. Anaemia, raised erythrocyte sedimentation rate and
a high disease activity score have all been identified as
risk factors for requirement of large joint arthroplasty
[5]. Seventeen percent of patients with RA undergo an* Correspondence: nickclement@doctors.org.uk
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reproduction in any medium, provided the ororthopaedic intervention within 5 years of initial diagno-
sis [5]. Over a third of patients will need a major joint
replacement, of which the majority will receive a total
hip or knee replacement (THR and TKR) [4]. This re-
view article summarises factors involved in the peri-
operative management of major lower limb arthroplasty
surgery for patients with RA.
Methods of literature search
We searched the PubMed.gov© [6] electronic database
for studies published in English between 1960 and 2011.
Our defined search term was: ‘rheumatoid’ ‘replacement’
‘arthroplasty’ and ‘outcome’. This identified 669 eligible
articles. All 669 abstracts were reviewed and those
matching the inclusion criteria were included, and the
full paper was retrieved.
The inclusion criteria were:
1. Articles reporting pre-operative management of
patients with RA receiving an orthopaedic
interventionl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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outcome and/or complications of primary total hip/
knee/ankle replacements in patients with RA
3. Articles reporting the survivorship and/or functional
outcome and/or complications of revision total hip/
knee/ankle replacements in patients with RA
4. Articles reporting the rehabilitation of patients with
RA after total hip/knee/ankle replacements
Due to the insufficiency of published literature regard-
ing arthroplasty in the patients with RA further litera-
ture searches were executed. This was only performed
when there was insufficient data to draw a conclusion
upon the question being addressed e.g. use of tumour
necrosis factor alpha (TNFα) drugs in patients with RA
undergoing arthroplasty surgery.Pre-operative assessment
Pre-operative: history, examination and investigations
need to be comprehensive (Table 1) [7].
Eighty percent of RA patients have cervical spine in-
volvement. Thirty percent have instability of the cervical
spine, half of whom are asymptomatic [8,9]. Subluxation
of the atlanto-axial joint, due to the destruction of the
transverse ligament by inflammatory pannus, is defined
as a distance of >3 mm between the anterior aspect of
the atlas and dens on a plain lateral cervical spine radio-
graph [7]. Clinical symptoms of occipital headache,Table 1 Systemic preoperative assessment of the
rheumatoid patient
History Examination Investigations
Disease onset Complete medical Full blood count









Soft tissue integrity Liver function tests
Morning stiffness Extra-articular features Chest radiograph
Functional limitations Grip strength Cervical spine
radiograph
Non-articular features General health Electrocardiogram











Drugs and allergies Airway assessmentweakness of limbs, bladder and bowel dysfunction, and
long track signs should alert the clinician to such path-
ology. Computerised tomography (CT) may be helpful
to assess the extent of subluxation [10].
Immunosuppressants
Steroids are used as a therapeutic bridge to control the
symptoms until the disease modifying anti rheumatic
drugs (DMARDs) take effect. If a patient has used long-
term steroids, an increased dose should be given in
times of stress to prevent an Addisionian crisis. Use of
steroids in the peri-operative period for general surgical
procedures increases the infection rate and impedes
wound healing [11]. There is, however, no published lit-
erature regarding the risk of steroid use in the peri-
operative period for arthroplasty surgery.
Methotrexate is a commonly used DMARD and has
been shown to improve symptoms and slow radiographic
progression of joint destruction [12]. There is a single
prospective randomised control trial, which recruited
388 patients undergoing elective surgery who were ran-
domised to either cease or continue with methotrexate
[13]. They demonstrated a 2% infection rate in those who
continued methotrexate, with a decreased complication
rate and number of flares of their rheumatoid disease.
Those who stopped the methotrexate, had a 15% infec-
tion rate. Hence it would seem safe and beneficial for the
patient to continue their methotrexate peri-operatively,
and may aid their post-operative recovery.
Newer targeted immunotherapy such as TNFα antago-
nists are more effective in disease control with slowing
of radiographic joint destruction [14]. The evidence as
to whether these drugs should be continued or stopped
during orthopaedic procedures is limited. One study of
31 patients undergoing foot and ankle surgery demon-
strated no difference in the infection rate if patients con-
tinued with their TNFα prescription [15]. A larger
retrospective study of 128 patients undergoing major
orthopaedic surgery revealed an increased infection risk
in those who remained on TNFα antagonists (odds ratio
21.8), and an associated increased risk of deep vein
thrombosis (odds ratio 2.8) [16].
Surgical sequence
Wilkinson et al suggested addressing lower limb arthro-
pathy before the upper limb; with the hypothesis that
prior fragile upper limb interventions may be damaged
by mobilisation on crutches after lower limb surgery [7].
The surgical sequence they recommended was: forefoot,
hip, knee, hind foot and then ankle, which they deemed
the order of “reliability” of the procedures. Constructing
a base on which you can build would be logical, the
“reliability” of different procedures is arguable and
individual patient assessment may dictate a different
Figure 1 Grade II protrusio acetabuli (A) in a female that
underwent THR with medial bone graft and restoration of the
center of rotation (B).
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immobilization, and could be considered at an earlier
stage. Restoration of the correct femoral alignment and
length with a THR precedes the TKR to allow correct im-
plant alignment and rotation. Significant joint stiffness
and/or contracture at adjacent or bilateral joints may be
optimally addressed by simultaneous arthroplasty sur-
gery. Pre-operative long leg standing alignment radio-
graphs and a CT scan for assessment of soft tissue
integrity and bone loss can help plan surgery.
Total hip replacement
Technical challenges of performing THR in patients with
RA are mainly due to bone loss, osteopenia and protrusio
acetabuli. These patients are not suitable for hip resur-
facing because of the risk of secondary osteoporosis [17].
Until recently there has been little evidence to support
the use of cemented over uncemented THR. Chmell et
al reviewed 39 patients with juvenile rheumatoid disease
(66 hips) who received a cemented THR with a mean
follow of 15.1 years [18]. They report a stem survival of
85% and a cup survival of 70%, for various implant
designs. Creighton et al reviewed 75 patients (106 hips)
all of whom received a cemented prosthesis and revealed
a stem survival of 98% and cup survival of 92% at
10 years [19]. They also demonstrated an association of
cup loosening with younger patients. Jana et al, using an
uncemented stem in 64 patients (82 hips) for juvenile
RA, reported a survival of 98.1% at 11 years. However,
various cemented and uncemented cups were used. Ana-
lysis of 2,557 primary THR using various implants for
patients with RA from the Finnish arthroplasty register
found the best survival to be with uncemented proxim-
ally circumferentially porous-coated stems (89% survival
at 15 years) and cemented all-polyethylene cups (80%
survival at 15 years) [20]. However, more recent data
from the Norwegian arthroplasty register suggested that
cemented THR was superior to uncemented THR, with
a 10 year survival of 89% and 81% respectively [21].
Protrusio acetabuli is a common occurrence in the
rheumatoid hip and technical difficulties can be encoun-
tered due to medial wall deficiency. Two grading sys-
tems are used; that of Charnley [22], relative to the
ilio-pectineal line, and more commonly Hirst et al. [23],
relative to the ilio-ischial line (Table 2). Hirst alsoTable 2 Grading of protrusio acetabuli according to the
distance between the acetabular line (medial wall of
acetabulum) and the ilio-ischial line25
Grade Men Women
I 3-8 mm 6-11 mm
II 8-13 mm 12-17 mm
III >13 mm with fragmentation >17 mm with fragmentationdescribed the Wrightington technique for bone grafting
the acetabular floor, using 2 mm discs cut from the dislo-
cated femoral head, which are molded using a dome
pusher to conform to the acetabular floor. Restoration of
the center of rotation lateral to Köhler’s teardrop is es-
sential (Figure 1). To further improve cement fixation
6 mm holes may be drilled around the periphery of the
acetabulum. The cement is placed directly onto the floor
graft with insertion of the cup. More extensive acetabular
destruction in Grade III protrusio may require a cage
and additional bone grafting to prevent early failure
(Figure 2).Total knee replacement
Poor bone stock, avascular necrosis, deformity and con-
tracture (Figure 3) can present technical challenges. Im-
plant augmentation and bone grafting may be required.
A posterior cruciate ligament (PCL) retaining implant
is favoured by many surgeons for osteoarthritis of the
knee. However, in rheumatoid disease there is soft tissue
destruction resulting in joint instability. Even if the PCLFigure 2 Grade III protrusio acetabuli (A) with cage
augmentation and medial bone graft (B).
Figure 3 Valgus deformity of knee (A) due to avascular
necrosis and bone destruction (B).
Figure 4 Significant valgus deformity and concomitant medial
collateral attenuation (A) managed with a rotating hinge TKR (B).
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eroded by inflammatory pannus post-operatively result-
ing in an unstable prosthetic joint. Laskin reviewed 178
rheumatoid patients at an average of 8.2 years follow-up
and demonstrated a 50% instability rate with PCL retain-
ing implants in contrast to a 1% instability rate with the
PCL sacrificing implants [24]. Longer-term results in
rheumatoid disease are limited, Goldberg et al. [25] and
Kristensen et al. [26] demonstrated a 0% to 14% instabil-
ity rate for PCL sacrificing implants respectively. Gill
et al. [27] and Meding et al [28] have also shown similar
rates of instability for PCL retaining implants (1.5% and
9.9% respectively). The differences between the reported
instability rates may relate to disease severity and med-
ical treatment, with more recent studies having the ad-
vantage of modern pharmacokinetics and preservation
of soft tissues.
Patients with significant valgus deformity and con-
comitant medial collateral attenuation, a rotating hinge
(Figure 4) may be the treatment of choice [29], as an ex-
tensive lateral release may result in “overstuffing” of the
joint with an increased risk of mid-flexion instability.
Furthermore if the patient has a marked fixed flexion
contracture of >30 degrees, then threshold for a con-
strained design should be low, particularly in the elderly
patient [30].
The 15 year survival excluding infection for cemented
total knee arthroplasty in RA is 96.5% and 91% for PCL
retaining and PCL sacrificing implants respectively
[28,31]. However, it could be argued that the increased
failure rate in those who received a PCL sacrificing im-
plant had a higher grade of rheumatoid disease with se-
vere joint destruction and hence the indication of
a stabilised implant. Cemented implants may be the
preferred option in poor bone stock and osteoporosis.
Vigano et al described a 10-year survival rate of 98.4%
using an uncemented TKR for RA patients. The average
age of their cohort was 49.5 years; and it could beargued that these patients had a better bone stock than
elderly patients facilitating osteointegration.
Shoji et al conducted a retrospective comparison of
rheumatoid patients undergoing TKR with and without
patella resurfacing and demonstrated no difference in
pain or functional outcome [32]. In contrast Kajino et al
conducted a prospective randomised control trial of
rheumatoid patients undergoing TKR and demonstrated
improved pain relief and functional outcomes for
patients receiving patella resurfacing [33].
Total ankle replacement
The survival of total ankle replacement (TAR) does not
parallel that of THR and TKR. The reported success rate
of TAR in RA ranges from 40 to 100% [34]. Mechanical
loosening of the components is the major cause of revi-
sion surgery [35]. A recent long-term follow-up of 33
TAR for RA reported an 85% survival rate at 10 years
when failure was defined as removal of the prosthesis,
this decreased to 64% if signs of radiographic loosening
were included [35].
Failure after TAR has been shown to be much higher
in patients with greater than fifteen degrees of varus or
valgus deformity [36,37]. When a concomitant planoval-
gus, forefoot abductus deformity exists, arthroplasty is a
more difficult and is a less predictable procedure. Suc-
cess will require a simultaneous, or two-stage triple arth-
rodesis to correct the deformity, which is generally too
severe to be corrected with a simple subtalar fusion.
Patients are often frail or have poor soft tissues making
two stage operations unattractive and a simultaneous
triple arthrodesis a high risk venture.
Revision arthroplasty surgery
There is limited data regarding revision THR in rheuma-
toid patients. The outcome of cemented cup revision for
RA is inferior to patients without RA with a 64% radio-
graphic failure rate at 7 years [38]. This survival rate falls
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used at revision [39]. Schreurs et al improved survival
with the application of morselised bone graft in combin-
ation with a cemented cup at revision, reporting an 80%
survival at 12 years [40].
High failure rates have been reported for revision TKR
in patients with RA. Garcia et al. report a survival for all
knees (27 mechanical failures and 18 infected revisions)
of 76% at 5 years. They also, more worryingly, report a
34 % mortality rate at 6 months for RA patients revised
for infection [41].
Rehabilitation
Patients with RA have a longer length of hospital stay
with slower functional improvement than patients
undergoing joint replacement surgery for primary osteo-
arthritis. A study of 1,361 rheumatoid patients and
26,096 osteoarthritic patients undergoing lower limb
arthroplasty found the length of stay to be only one day
longer, but did show a slower, more gradual improve-
ment of their functional independence score [42]. Stan-
ley et al demonstrated that RA patients undergoing
bilateral TKR had a similar functional outcome and
complication rate as those undergoing staged proce-
dures, but they had the benefit of a more rapid recovery
relative to staged procedures [43].
Complications
Evidence from the Swedish joint registry suggests that
periprosthetic fractures are more common among
patients with rheumatoid disease compared to osteoarth-
ritis patients, with a hazard ratio (HR) of 1.56 [44]. Simi-
lar figures have been reported from the Finnish registry
(HR 2.1) [45]. This predisposition to fracture may to be
secondary to poor bone quality [45]. The management
of peri-prosthetic fractures can be challenging and asso-
ciated with high morbidity and mortality [43].
The risk of arthroplasty infection is greater for patients
with RA. Bongartz et al conducted a retrospective review
of 462 patients (657 implants) who received either a
TKR or THR, they compared infection rates for both
RA patients and with a matched cohort of patients with
osteoarthritis [46]. They found RA patients to be at an
increased risk of prosthetic joint infections for both pri-
mary (HR 4.08, 95% CI 1.35-12.33) and revision surgery
(HR 2.99, 95% 1.02-8.75).
Conflicting evidence exists regarding the risk of ven-
ous thromboembolism (VTE) post arthroplasty surgery
in RA, with Chotanaphuti et al. [47] declaring RA to be
a risk factor and Guan et al. [48] claiming RA to be pro-
tective for VTE. A retrospective review of nearly 5 mil-
lion patients with RA showed that RA was an
independent risk factor for pulmonary embolism and
deep vein thrombosis in hospital patients who did notundergo surgery, with a relative risk of 2.25 and 1.9 re-
spectively [49].
Patient outcomes
Those patients with active disease, raised rheumatoid
titre or clinical depression do not improve to the same
extent as those patients without [50]. Ethgen et al per-
formed a cost/outcome analysis of arthroplasty for
patients with RA finding good pain relief that was equal
to those with primary osteoarthritis, but there was only
a minor improvement in the functional outcome [51].
They also demonstrated reduced use of DMARDS, with
cost savings, which may relieve the patient of their side-
effects. Sledge proposed the key to a successful surgical
outcome for patients with RA is for the surgeon to be
familiar with the technical challenges of patients with
polyarthritis and to work as part of a multidisciplinary
team [1].
Summary
RA is a systemic disease and like any other medical
comorbidity, the patient should be optimised pre-
operatively using a multidisciplinary approach. The con-
tinued use of methotrexate does not increase infection
risk, and aids an early recovery with control of the dis-
ease during the peri-operative period. Biologic agents
(TNFα antagonists) should be stopped pre-operatively
due the increased infection rate. Patients should be
made aware pre-operatively of the increased risk of in-
fection and periprosthetic fracture rates associated with
their disease.
The surgical sequence is commonly hip, knee and then
ankle. Cemented THR and TKR have superior survival
rates over uncemented components in RA patients. The
need for bone grafting for protrusio acetabuli should be
identified during pre-operative planning. The evidence is
not clear regarding a PCL sacrificing versus retaining in
TKR, but a PCL sacrificing component limits the risk
early instability and potential revision. Patella resurfacing
as part of a TKR is associated with improved outcomes
and should be considered in the rheumatoid patient.
The results of TAR remain inferior to THR and TKR.
RA patients achieve equivalent pain relief, but their re-
habilitation is slower and their functional outcome is not
as good. However, the key to managing these compli-
cated patients is to work as part of a multidisciplinary
team to optimise their outcome.
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